Literature DB >> 18178776

Gene overexpression/suppression analysis of candidate virulence factors of Candida albicans.

Yue Fu1, Guanpingsheng Luo, Brad J Spellberg, John E Edwards, Ashraf S Ibrahim.   

Abstract

We developed a conditional overexpression/suppression genetic strategy in Candida albicans to enable simultaneous testing of gain or loss of function in order to identify new virulence factors. The strategy involved insertion of a strong, tetracycline-regulated promoter in front of the gene of interest. To validate the strategy, a library of genes encoding glycosylphosphatidylinositol (GPI)-anchored surface proteins was screened for virulence phenotypes in vitro. During the screening, overexpression of IFF4 was found to increase the adherence of C. albicans to plastic and to human epithelial cells, but not endothelial cells. Consistent with the in vitro results, IFF4 overexpression modestly increased the tissue fungal burden during murine vaginal candidiasis. In addition to the in vitro screening tests, IFF4 overexpression was found to increase C. albicans susceptibility to neutrophil-mediated killing. Furthermore, IFF4 overexpression decreased the severity of hematogenously disseminated candidiasis in normal mice, but not in neutropenic mice, again consistent with the in vitro phenotype. Overexpression of 12 other GPI proteins did not affect normal GPI protein cell surface accumulation, demonstrating that the overexpression strategy did not affect the cell capacity for making such proteins. These data indicate that the same gene can increase or decrease candidal virulence in distinct models of infection, emphasizing the importance of studying virulence genes in different anatomical contexts. Finally, these data validate the use of a conditional overexpression/suppression genetic strategy to identify candidal virulence factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178776      PMCID: PMC2268510          DOI: 10.1128/EC.00445-07

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  53 in total

1.  A recyclable Candida albicans URA3 cassette for PCR product-directed gene disruptions.

Authors:  R B Wilson; D Davis; B M Enloe; A P Mitchell
Journal:  Yeast       Date:  2000-01-15       Impact factor: 3.239

2.  Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans.

Authors:  A Sonneborn; D P Bockmühl; M Gerads; K Kurpanek; D Sanglard; J F Ernst
Journal:  Mol Microbiol       Date:  2000-01       Impact factor: 3.501

Review 3.  Comprehensive analysis of glycosylphosphatidylinositol-anchored proteins in Candida albicans.

Authors:  Mathias L Richard; Armêl Plaine
Journal:  Eukaryot Cell       Date:  2006-12-22

4.  Candida albicans Iff11, a secreted protein required for cell wall structure and virulence.

Authors:  Steven Bates; José M de la Rosa; Donna M MacCallum; Alistair J P Brown; Neil A R Gow; Frank C Odds
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

5.  Function of Candida albicans adhesin Hwp1 in biofilm formation.

Authors:  Clarissa J Nobile; Jeniel E Nett; David R Andes; Aaron P Mitchell
Journal:  Eukaryot Cell       Date:  2006-10

6.  The cell wall architecture of Candida albicans wild-type cells and cell wall-defective mutants.

Authors:  J C Kapteyn; L L Hoyer; J E Hecht; W H Müller; A Andel; A J Verkleij; M Makarow; H Van Den Ende; F M Klis
Journal:  Mol Microbiol       Date:  2000-02       Impact factor: 3.501

7.  A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence.

Authors:  D Sanglard; B Hube; M Monod; F C Odds; N A Gow
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

Review 8.  Recent developments in molecular genetics of Candida albicans.

Authors:  M D De Backer; P T Magee; J Pla
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

9.  Disruption of Candida albicans IFF4 gene involves modifications of the cell electrical surface properties.

Authors:  Marie Kempf; Véronique Apaire-Marchais; Patrick Saulnier; Patricia Licznar; Corinne Lefrançois; Raymond Robert; Jane Cottin
Journal:  Colloids Surf B Biointerfaces       Date:  2007-03-28       Impact factor: 5.268

10.  Rad6p represses yeast-hypha morphogenesis in the human fungal pathogen Candida albicans.

Authors:  P Leng; P E Sudbery; A J Brown
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

View more
  24 in total

1.  E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis.

Authors:  Nao-Aki Watanabe; Mamiko Miyazaki; Takaaki Horii; Koji Sagane; Kappei Tsukahara; Katsura Hata
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

Review 2.  Adhesins in human fungal pathogens: glue with plenty of stick.

Authors:  Piet W J de Groot; Oliver Bader; Albert D de Boer; Michael Weig; Neeraj Chauhan
Journal:  Eukaryot Cell       Date:  2013-02-08

3.  The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicans.

Authors:  Nathan P Wiederhold; Laura K Najvar; Annette W Fothergill; Dora I McCarthy; Rosie Bocanegra; Marcos Olivo; William R Kirkpatrick; Michael P Everson; Frederick P Duncanson; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2014-10-20       Impact factor: 5.191

Review 4.  Candida albicans interactions with epithelial cells and mucosal immunity.

Authors:  Julian R Naglik; David L Moyes; Betty Wächtler; Bernhard Hube
Journal:  Microbes Infect       Date:  2011-07-14       Impact factor: 2.700

5.  Application of the systematic "DAmP" approach to create a partially defective C. albicans mutant.

Authors:  J S Finkel; N Yudanin; J E Nett; D R Andes; A P Mitchell
Journal:  Fungal Genet Biol       Date:  2011-07-27       Impact factor: 3.495

6.  Candida albicans virulence and drug-resistance requires the O-acyltransferase Gup1p.

Authors:  Célia Ferreira; Sónia Silva; Fábio Faria-Oliveira; Eva Pinho; Mariana Henriques; Cândida Lucas
Journal:  BMC Microbiol       Date:  2010-09-15       Impact factor: 3.605

7.  Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.

Authors:  Melyssa Negri; Margarida Martins; Mariana Henriques; Terezinha I E Svidzinski; Joana Azeredo; Rosário Oliveira
Journal:  Mycopathologia       Date:  2009-10-23       Impact factor: 2.574

8.  Disruption of the GPI protein-encoding gene IFF4 of Candida albicans results in decreased adherence and virulence.

Authors:  Marie Kempf; Jane Cottin; Patricia Licznar; Corinne Lefrançois; Raymond Robert; Véronique Apaire-Marchais
Journal:  Mycopathologia       Date:  2009-04-05       Impact factor: 2.574

9.  A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  John E Edwards; Michael M Schwartz; Clint S Schmidt; Jack D Sobel; Paul Nyirjesy; Florian Schodel; Erica Marchus; Mary Lizakowski; Elizabeth A DeMontigny; Jesse Hoeg; Tuomas Holmberg; M Timothy Cooke; Keila Hoover; Lance Edwards; Mark Jacobs; Steven Sussman; Michael Augenbraun; Michael Drusano; Michael R Yeaman; Ashraf S Ibrahim; Scott G Filler; John P Hennessey
Journal:  Clin Infect Dis       Date:  2018-06-01       Impact factor: 9.079

Review 10.  Interactions of Candida albicans with epithelial cells.

Authors:  Weidong Zhu; Scott G Filler
Journal:  Cell Microbiol       Date:  2009-11-16       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.